C07C 217/04
The carbon skeleton being acyclic and saturated
Official title: the carbon skeleton being acyclic and saturated
C07C217/04 (The carbon skeleton being acyclic and saturated) appears on 1,153 US grants and 1,049 published applications in this corpus.
Search patents in C07C- Granted patents
- 1,153
- Published applications
- 1,049
- Assignees
- 683
- Inventors
- 3,077
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 4 | 0 |
| 1978 | 3 | 0 |
| 1979 | 3 | 0 |
| 1980 | 2 | 0 |
| 1981 | 0 | 0 |
| 1982 | 3 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 2 | 0 |
| 1987 | 2 | 0 |
| 1988 | 3 | 0 |
| 1989 | 17 | 0 |
| 1990 | 9 | 0 |
| 1991 | 28 | 0 |
| 1992 | 23 | 0 |
| 1993 | 31 | 0 |
| 1994 | 25 | 0 |
| 1995 | 32 | 0 |
| 1996 | 34 | 0 |
| 1997 | 34 | 0 |
| 1998 | 31 | 0 |
| 1999 | 23 | 0 |
| 2000 | 28 | 0 |
| 2001 | 28 | 8 |
| 2002 | 31 | 32 |
| 2003 | 25 | 38 |
| 2004 | 22 | 60 |
| 2005 | 24 | 50 |
| 2006 | 37 | 50 |
| 2007 | 29 | 26 |
| 2008 | 38 | 45 |
| 2009 | 30 | 40 |
| 2010 | 27 | 43 |
| 2011 | 20 | 50 |
| 2012 | 29 | 43 |
| 2013 | 33 | 56 |
| 2014 | 49 | 51 |
| 2015 | 52 | 64 |
| 2016 | 57 | 48 |
| 2017 | 39 | 46 |
| 2018 | 27 | 39 |
| 2019 | 33 | 32 |
| 2020 | 27 | 40 |
| 2021 | 31 | 36 |
| 2022 | 27 | 40 |
| 2023 | 27 | 30 |
| 2024 | 33 | 41 |
| 2025 | 20 | 24 |
| 2026 | 16 | 17 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C07C 217/06Having only one etherified hydroxy group and one amino group bound to818
- C07C 217/28Having one amino group and at least two singly-bound oxygen atoms, with339
- C07C 217/42Having etherified hydroxy groups and at least two amino groups bound to49
- C07C 217/26Having only one etherified hydroxy group and one amino group bound to15
Recent patents
- Nanomaterials comprising acetals6 Oct 2026US 12,753,147 B2Beam Therapeutics Inc.
- Nitrogen-branched non-linear pegylated lipid containing a tertiary amine and application thereof18 Aug 2026US 12,708,675 B2Xiamen Sinopeg Biotech Co., Ltd.
- Compound, cellular vesicle staining agent, and method of fluorescent staining for cellular vesicles11 Aug 2026US 12,704,443 B2National University Corporation Tokai National Higher Education and Research System
- Valiolamine derivatives as glucosidase inhibitors7 Jul 2026US 12,673,924 B2Emergent Product Development Gaithersburg Inc.
- Branched type hetero monodispersed polyethylene glycol, production method thereof, and conjugate thereof7 Jul 2026US 12,674,025 B2Nof Corporation
- Methods for making and using endoxifen24 Sep 2026US 2026/0285798 A1Atossa Therapeutics, Inc.
- Carbonate containing lipid compounds and compositions for intracellular delivery of therapeutic agents17 Sep 2026US 2026/0274784 A1ModernaTX, Inc.
- Functionalized thermoplastic polyurethane, method for producing same, method for producing highly functional medical composite material using same, and medical device including same20 Aug 2026US 2026/0242532 A1I-Sens, Inc.
- Amino lipid compound, and preparation method therefor and use thereof30 Jul 2026US 2026/0217645 A1Shenzhen Shenxin Biotechnology Co., Ltd.
- Surfactant compositions derived from waste streams, and methods30 Jul 2026US 2026/0218053 A1Kemira Oyj
Most cited
By later US patents
- Cationic lipids and methods for the delivery of therapeutic agents380US 8,569,256 B2Protiva Biotherapeutics, Inc. · 2013
- Cationic lipids334US 5,334,761 ALife Technologies Corporation · 1994
- Cationic lipids and methods of use267US 7,745,651 B2Protiva Biotherapeutics, Inc. · 2010
- Lipids and compositions for intracellular delivery of biologically active compounds247US 8,691,750 B2Axolabs GmbH · 2014
- Non-nucleoside linkers for convenient attachment of labels to oligonucleotides using standard synthetic methods234US 5,414,077 AGilead Sciences, Inc. · 1995